We are live on ! Find out more
HM

HealthCor Management Portfolio holdings

AUM $109M
1-Year Est. Return 10.64%
This Fund
S&P 500
This Quarter Est. Return
+20.67%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$2.1B
AUM Growth
+$302M
Cap. Flow
+$69.4M
Cap. Flow %
3.31%
Top 10 Hldgs %
39.8%
Holding
89
New
37
Increased
12
Reduced
15
Closed
24

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$75.2M
2
AET
Aetna Inc
AET
+$68.6M
3
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$55.8M
4
BKD icon
Brookdale Senior Living
BKD
+$51.1M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$50.4M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$120M
2
BHC icon
Bausch Health
BHC
+$93M
3
PFE icon
Pfizer
PFE
+$76.9M
4
KEYS icon
Keysight
KEYS
+$69M
5
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$60.3M

Sector Composition

Rank Sector Weight
1 Healthcare 60.75%
2 Financials 3.56%
3 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZBH icon
76
CALL
Zimmer Biomet
ZBH
$18.9B
– –
-412,000
Closed -$45.4M
ZBH icon
77
Zimmer Biomet
ZBH
$18.9B
– –
-272,332
Closed -$30M
ZTS icon
78
Zoetis
ZTS
$31B
– –
-512,500
Closed -$22.1M
INFI
79
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
– –
-223,712
Closed -$3.78M
NUVA
80
DELISTED
NuVasive, Inc.
NUVA
– –
-750,000
Closed -$35.4M
BLCM
81
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
– –
-4,059
Closed -$935K
ALXN
82
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-127,100
Closed -$23.5M
VAR
83
PUT
DELISTED
Varian Medical Systems, Inc.
VAR
– –
-114,038
Closed -$8.65M
ACHN
84
CALL
DELISTED
Achillion Pharmaceuticals
ACHN
– –
-100,000
Closed -$1.23M
KERX
85
DELISTED
Keryx Biopharmaceuticals Inc
KERX
– –
-178,300
Closed -$2.52M
CEMP
86
DELISTED
Cempra, Inc.
CEMP
– –
-11,408
Closed -$268K
OCR
87
DELISTED
OMNICARE INC
OCR
– –
-675,000
Closed -$49.2M
SLXP
88
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
– –
-525,000
Closed -$60.3M
CELG
89
DELISTED
Celgene Corp
CELG
– –
-181,600
Closed -$20.3M
1 2 3
4

Similar funds

IA
Integrity Advisory Overland Park, Kansas $109M AUM 15.71% 1-Year Est. Return
EPC
Emerson Point Capital Larchmont, New York $108M AUM 19.03% 1-Year Est. Return
TCMV
Technology Crossover Management VII Menlo Park, California $107M AUM 51.05% 1-Year Est. Return
SI
Salesforce Inc San Francisco, California $114M AUM 53.18% 1-Year Est. Return
HCWM
Harrison & Co Wealth Management Roanoke, Virginia $103M AUM 9.82% 1-Year Est. Return
PC
Phoenician Capital New York $117M AUM 9.46% 1-Year Est. Return
RF
Resolute Financial Newburyport, Massachusetts $118M AUM 11.75% 1-Year Est. Return
AWM
Align Wealth Management Oklahoma City, Oklahoma $118M AUM

HealthCor Management's Q1 2015 Portfolio in Review

As of Q1 2015, HealthCor Management held 89 positions worth $2.1B, up 17% from $1.79B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

HealthCor Management deployed $69.4M of net new capital in Q1 2015, opening 37 new positions and adding to 12 existing holdings. Its largest new stake was Biogen: 190,700 shares worth $80.5M.

By sector, the portfolio is most concentrated in Healthcare at 61% of assets, down from 72% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Gilead Sciences, an estimated $120M trimmed.

  • HealthCor Management's largest Q1 2015 buy was Biogen: 190,700 shares worth $80.5M.
  • HealthCor Management added most to Brookdale Senior Living in Q1 2015, an estimated $51.1M increase.
  • HealthCor Management's biggest Q1 2015 reduction was Gilead Sciences, cutting an estimated $120M.
  • HealthCor Management fully exited Bausch Health in Q1 2015, selling an estimated $93M.
  • HealthCor Management's ten largest holdings make up 40% of its $2.1B portfolio in Q1 2015.
  • HealthCor Management opened 37 new positions and closed 24 in Q1 2015.
  • HealthCor Management's portfolio value rose 17% quarter-over-quarter to $2.1B.

Based on HealthCor Management's 13F filing for Q1 2015, filed 15 May 2015.